Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value ($000): $241,512 (100.0% shares, 0.0% debt)

Holdings (11)

CRSP CRISPR Therapeutics AG 23.1%

Value ($000) $55,804 Shares 498,558 Est. Cost $40.26 Unrealized +211.9%

— Passage Bio, Inc. 20.5%

Value ($000) $49,399 Shares 4,959,769 Est. Cost $17.48 Unrealized —

— Gritstone Oncology, Inc. 17.9%

Value ($000) $43,264 Shares 4,005,894 Est. Cost $7767.86 Unrealized —

— Aligos Therapeutics, Inc. 14.9%

Value ($000) $35,989 Shares 2,320,381 Est. Cost $27.65 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 7.2%

Value ($000) $17,276 Shares 820,720 Est. Cost $17.05 Unrealized +22.7%

— Akero Therapeutics, Inc. 5.7%

Value ($000) $13,806 Shares 617,727 Est. Cost $21200.00 Unrealized —

— Adverum Biotechnologies, Inc. 4.6%

Value ($000) $10,998 Shares 5,068,233 Est. Cost $9646.10 Unrealized —

— Aprea Therapeutics, Inc 2.7%

Value ($000) $6,437 Shares 1,259,662 Est. Cost $38780.00 Unrealized —

— Flexion Therapeutics, Inc. 2.5%

Value ($000) $6,100 Shares 1,000,000 Est. Cost $10.41 Unrealized —

— CymaBay Therapeutics, Inc. 0.8%

Value ($000) $1,985 Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.2%

Value ($000) $454 Shares 101,855 Est. Cost $56000.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	498,558	$55,804	23.1%	$40.26	+211.9%	Common Shares	H17182108
—	Passage Bio, Inc.	4,959,769	$49,399	20.5%	$17.48	—	Common Stock	702712100
—	Gritstone Oncology, Inc.	4,005,894	$43,264	17.9%	$7767.86	—	Common Stock	39868T105
—	Aligos Therapeutics, Inc.	2,320,381	$35,989	14.9%	$27.65	—	Common Stock	01626L105
CRNX	Crinetics Pharmaceuticals, Inc.	820,720	$17,276	7.2%	$17.05	+22.7%	Common Stock	22663K107
—	Akero Therapeutics, Inc.	617,727	$13,806	5.7%	$21200.00	—	Common Stock	00973Y108
—	Adverum Biotechnologies, Inc.	5,068,233	$10,998	4.6%	$9646.10	—	Common Stock	00773U108
—	Aprea Therapeutics, Inc	1,259,662	$6,437	2.7%	$38780.00	—	Common Stock	03836J102
—	Flexion Therapeutics, Inc.	1,000,000	$6,100	2.5%	$10.41	—	Common Stock	33938J106
—	CymaBay Therapeutics, Inc.	543,753	$1,985	0.8%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$454	0.2%	$56000.00	—	Common Stock	189464100